Travere Therapeutics to Present at Multiple Investor Conferences

Travere Therapeutics Inc. (TVTX) will participate in several upcoming investor conferences, including the Canaccord Genuity 45th Annual Growth Conference and the Cantor Global Healthcare Conference 2025. The company will provide live webcasts of its presentations, available on its Investor page. The participation highlights Travere's commitment to communicating its mission and progress in rare disease therapies.

Travere Therapeutics, Inc. (TVTX) has announced its participation in several upcoming investor conferences, including the Canaccord Genuity 45th Annual Growth Conference and the Cantor Global Healthcare Conference 2025. The company will present at these events, providing investors and industry professionals with insights into its mission and progress in rare disease therapies. The presentations will be available live via webcast on Travere's Investor page at ir.travere.com/events-and-presentations, with replays accessible for up to 30 days following each event.

The Canaccord Genuity 45th Annual Growth Conference will take place on Wednesday, August 13, 2025, at 8:00 a.m. ET. The Citi's 2025 Biopharma Back to School Conference is scheduled for Tuesday, September 2, 2025, at 3:15 p.m. ET. Travere will also present at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, at 1:30 p.m. ET, and the Cantor Global Healthcare Conference 2025 on Thursday, September 4, 2025, at 2:45 p.m. ET.

Travere Therapeutics is committed to developing life-changing therapies for patients with rare diseases. The company's global team works closely with the rare disease community to identify, develop, and deliver innovative treatments. By participating in these investor conferences, Travere aims to communicate its mission and progress to a broader audience, fostering a deeper understanding of its efforts in the rare disease space.

References:
[1] https://ir.travere.com/press-releases/news-details/2025/Travere-Therapeutics-to-Participate-at-Upcoming-Investor-Conferences-e8c0b6adb/default.aspx
[2] https://www.morningstar.com/news/business-wire/20250805058669/travere-therapeutics-to-participate-at-upcoming-investor-conferences
[3] https://www.marketscreener.com/news/travere-therapeutics-to-participate-at-upcoming-investor-conferences-ce7c5ed8df81f121